Company patents

ThermoLife International, LLC

ThermoLife International, LLC's patent strategy is overwhelmingly concentrated in Pharmaceutical Preparations, representing 98.9% of its portfolio, with an astonishing 210.5% growth in 2026 so far, indicating a massive surge in pharma innovation. While Therapeutic Activity (Pharma) patents have seen a decline of 20.0% in 2026, the company is rapidly expanding its focus on specific chemical structures, with Acyclic / Carbocyclic Compounds growing by 350.0% and Heterocyclic Compounds (Pharma) by 390.9% in 2026, suggesting a deep dive into novel compound development within its core pharmaceutical domain.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

95 US filings (since 2023) · 7 categories · 2 themes

Patents

Showing 1-10 of 163

Page 1 of 17